Drug · DIN 02425009
CONTINGENCY ONE
Yes: authorized and sold in Canada
Authorized, and the company reports that it sells it in Canada.
Status Marketed since May 29, 2026; first marketed August 31, 2015.
- Drug Identification Number (DIN)
- 02425009
- Company (DIN owner)
- Senador Laboratories Private LimitedHyderabad, Telangana, India
- Schedule
- Non-prescription drugs
- Dosage form
- Tablet
- Route
- Oral
- Therapeutic class (ATC)
- Levonorgestrel G03AD01
- Class
- Human
- Record last updated
- June 1, 2026
Active ingredients
As listed in the Drug Product Database.
| Ingredient | Strength | Per |
|---|---|---|
| LEVONORGESTREL | 1.5 MG |
Notices of Compliance
Health Canada approvals that name this DIN.
- May 29, 2026: NOC 37626New Drug Submission (NDS) · Administrative: Change in product ownership
- June 30, 2025: NOC 35605Supplement to a New Drug Submission (SNDS) · Update to Product Monograph (to align with supporting PM)
- March 16, 2018: NOC 20758Supplement to a New Drug Submission (SNDS) · Updates in the product monograph (pm) and labels for contingency one to align with recent updates made to the pm of the reference product
- April 18, 2016: NOC 18005New Drug Submission (NDS) · Transfer of drug identification number
- August 31, 2015: NOC 17241New Drug Submission (NDS) · Manufacturer name change
- May 28, 2015: NOC 16946New Drug Submission (NDS)